FDA to expand Sentinel in five-year plan

FDA announced Wednesday a five-year plan to expand the analysis capabilities of its Sentinel safety monitoring platform and leverage the platform to accelerate the use of real-world evidence.

Sentinel allows FDA to run queries that look for postmarketing safety signals across data sets from U.S. insurance companies and healthcare providers. The database was built to incorporate primarily insurance claims data, electronic health records and registry data...